C-(3,4-DIMETHOXY-BICYCLO[4.2.0]OCTA-1(6),2,4-TRIEN-7-YL)-METHYLAMINE CAS: 73344-75-9

Product Parameters
Catalog No. BK364P
CAS.RN 73344-75-9
Molecular Formula C11H15NO2
Molecular Weight 193.24 g/mol
Purity NLT 98%
Product Overview

C-(3,4-dimethoxybicyclo[4.2.0]oct-1(6),2,4-trien-7-yl)methylamine is an important pharmaceutical intermediate widely used in the construction and synthesis of novel drug molecules. This compound possesses a unique bicyclic structure and multiple functional groups, making it suitable for key steps in organic synthesis, particularly in the development of antitumor, antiviral, and central nervous system drugs. It can support the entire process from laboratory research to industrial production, suitable for small-scale, pilot-scale, and large-scale production stages, providing customers with a stable and reliable raw material supply.

Applications
  • Drug molecule construction and synthesis
  • Development of antitumor drug intermediates
  • Optimization of antiviral drug synthetic pathways
  • Research on central nervous system drugs
  • Customized pharmaceutical synthesis services
Quality & Supply Capability

English Name: C-(3,4-DIMETHOXY-BICYCLO[4.2.0]OCTA-1(6),2,4-TRIEN-7-YL)-METHYLAMINE Properties: This product is an aromatic compound with a bicyclic structure, containing 3,4-dimethoxy substituents and aminomethyl functional groups. It exhibits good chemical stability and reactivity, making it suitable for various organic synthesis reactions. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide comprehensive sample supply, small-scale preparation, pilot-scale amplification, and customized batch production services. We can flexibly adjust the supply plan according to the customer's specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documents. Simultaneously, we have a professional technical support team to assist customers in completing process development, route optimization, and project transformation, ensuring a smooth transition from laboratory research and development to large-scale production.

Why Choose Bioncan

Focused on pharmaceutical intermediates, possessing extensive synthesis experience and technological expertise. Full-scale supply capability, meeting diverse needs from laboratory to commercial production. Comprehensive quality control documentation support, including COA, MSDS, HPLC, NMR, etc. Customization support available, capable of synthesis and packaging design tailored to specific client requirements. Comprehensive process optimization and scale-up technical support to help clients efficiently advance their R&D and industrialization processes.

Intermediates of Ivabradine hydrochloride
Catalog No. Product Name CAS
BA05GW Ivabradine hydrochloride API 148849-67-6
BK82Q4 4,5-Dimethoxy-1-cyanobenzocyclobutane 35202-54-1
BK598V (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride 866783-13-3
BK33FJ 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one 73942-87-7
BK56VJ (S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methylmethanamine 866783-12-2
BK206L Dehydro ivabradine 1086026-31-4
BK4YJ2 N-(3-Bromopropyl)-Phthalimide 5460-29-7
BK3E8G 2,2-Dimethoxy acetaldehyde 51673-84-8
BK40K6 1,1-Diethoxyethene 2678-54-8
BK9D07 The metabolite of ivabradine 215935-23-2
BK752T 3,4-DimethoxyPhenylethylamine 120-20-7
BK364P C-(3,4-DIMETHOXY-BICYCLO[4.2.0]OCTA-1(6),2,4-TRIEN-7-YL)-METHYLAMINE 73344-75-9
BK96F9 (3,4-DiMethyoxy-bicyclo(4,2,0)octa-1(6),2,4-trien-7-ylMethyl)-carbaMic acid ethyl ester 148870-55-7
BK8YQ4 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one 148870-57-9
BK7CK9 Propanedioic acid, 2-​(2-​bromo-​4,​5-​dimethoxyphenyl)​-​, 1,​3-​dimethyl ester 1069115-30-5
BK1AT9 Bicyclo[4.2.0]​octa-​1,​3,​5-​triene-​7,​7-​dicarboxylic acid, 3,​4-​dimethoxy-​, 7,​7-​dimethyl ester 1069115-32-7
BK9Z16 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one hydrochloride 163629-94-5
BK813C 4,5-diMethoxy-N-Methyl-1,2-dihydrocyclobutabenzene-1-carboxaMide 1206230-27-4
BK2BU0 3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 148870-58-0
BK2PD7 3-(3-(((S)-4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one hydrochloride 1393427-01-4
BK5KH5 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-02-5
BK45M1 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(2,2-dimethoxyethyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-03-6
BK5EL6 (3,4-DiMethoxyphenyl)acetyl chloride 10313-60-7
BK8E10 7,8-Dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)acetyl)(methyl)amino)propyl)-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-04-7
BK2YU2 4,5-DIBROMOVERATROLE 37895-73-1
BK67FH (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1-oxide 1132079-01-6
BK2Z7N (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2-oxo-2,3-dihydro-1H-benzo[d]azepin-1-ium chloride 1246638-10-7
BK0F52 Bicyclo[4.2.0]​octa-​1,​3,​5-​triene-​7-​carboximidamide, 3,​4-​dimethoxy-​N-​methyl-​N-​[3-​(1,​2,​4,​5-​tetrahydro-​7,​8-​dimethoxy-​2-​oxo-​3H-​3-​benzazepin-​3-​yl)​propyl]​- 1246672-58-1
BK8Q64 7,8-Dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-2,3-dihydro-1H-benzo[d]azepin-2-one 98062-25-0
BK85JV 3-chloro-N-{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}-N-methyl-1-propanamine 1031767-71-1
BK5F84 (S)-N-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)-N-methyl-3-(7,8-dimethoxy-2-oxo-2,3-dihydro-1H-benzo[d]azepin-3-yl)propan-1-aminium chloride 1325209-22-0
BK515P (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one sulfate 1325209-23-1
BK5J56 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one mesylate 1325209-25-3
BK32MX (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one hydrobromide 1325209-24-2
BK1E79 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one phosphate 1325209-26-4
BK36R2 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one acetate 1325209-27-5
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 73344-75-9, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.